JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Financials | 11.06% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Healthcare | 9.57% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
InterContinental Hotels
IHG
$23.9B
| $22.2M | ﹤0.01% |
333,613
+14,359
| +4% | +$1.01M |
|
1702
BorgWarner
BWA
$14B
| $22.2M | ﹤0.01% |
520,212
-106,419
| -17% | -$4.69M |
|
1703
Urban Edge Properties
UE
$2.75B
| $22.2M | ﹤0.01% |
1,163,807
-277,291
| -19% | -$5.23M |
|
|
WBA
1704
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $22.2M | ﹤0.01% |
422,300
+198,600
| +89% | +$10.7M |
|
1705
Wyndham Hotels & Resorts
WH
$5.49B
| $22.2M | ﹤0.01% |
307,259
+32,875
| +12% | +$2.43M |
|
|
ICPT
1706
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $22.1M | ﹤0.01% |
1,108,855
+143,504
| +15% | +$2.84M |
|
|
TPTX
1707
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $22.1M | ﹤0.01% |
283,717
+252,994
| +823% | +$18.7M |
|
1708
Concentrix
CNXC
$1.5B
| $22.1M | ﹤0.01% |
137,375
+53,449
| +64% | +$8.22M |
|
1709
Under Armour Class C
UA
$2.2B
| $22.1M | ﹤0.01% |
1,188,116
-104,493
| -8% | -$1.97M |
|
|
NEE.PRQ
1710
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $22M | ﹤0.01% |
446,246
-137,049
| -23% | -$6.81M |
|
|
AL
1711
DELISTED
Air Lease Corp
AL
| $22M | ﹤0.01% |
527,888
-3,026
| -0.6% | -$141K |
|
1712
PUT
National Beverage
FIZZ
$2.9B
| $22M | ﹤0.01% |
465,900
+256,100
| +122% | +$12.4M |
|
1713
Manhattan Associates
MANH
$11.2B
| $22M | ﹤0.01% |
151,919
-13,450
| -8% | -$1.79M |
|
1714
PTC Therapeutics
PTCT
$6.06B
| $22M | ﹤0.01% |
520,041
+142,876
| +38% | +$6.12M |
|
1715
CRH
CRH
$65.2B
| $22M | ﹤0.01% |
431,905
+257,914
| +148% | +$12.9M |
|
1716
Popular Inc
BPOP
$11.2B
| $21.9M | ﹤0.01% |
292,149
-16,970
| -5% | -$1.3M |
|
1717
Unilever
UL
$133B
| $21.9M | ﹤0.01% |
332,932
-1,674
| -0.5% | -$111K |
|
1718
Brink's
BCO
$4.69B
| $21.9M | ﹤0.01% |
284,692
-4,043
| -1% | -$314K |
|
1719
Natural Resource Partners
NRP
$1.36B
| $21.8M | ﹤0.01% |
1,028,351
| – | – |
|
1720
Clear Channel Outdoor Holdings
CCO
$1.23B
| $21.8M | ﹤0.01% |
8,245,703
-164,319
| -2% | -$394K |
|
1721
Central Pacific Financial
CPF
$997M
| $21.8M | ﹤0.01% |
834,960
-154,840
| -16% | -$4.25M |
|
1722
Gildan
GIL
$10.6B
| $21.7M | ﹤0.01% |
587,140
-59,938
| -9% | -$2.1M |
|
1723
PUT
Johnson & Johnson
JNJ
$629B
| $21.6M | ﹤0.01% |
131,300
+130,600
| +18,657% | +$21.6M |
|
1724
Wabtec
WAB
$49.9B
| $21.6M | ﹤0.01% |
262,385
-246,469
| -48% | -$20M |
|
1725
PUT
Biogen
BIIB
$30.9B
| $21.6M | ﹤0.01% |
62,300
+52,300
| +523% | +$15.8M |
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q2 2021, opening 694 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 694 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.